Over-the-Counter (OTC) Healthcare Market Size was valued at USD 172.8 Billion in 2022. The Over-the-Counter (OTC) Healthcare Market industry is projected to grow from USD 177.1 Billion in 2023 to USD 215.80 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.50% during the forecast period (2024 - 2032). Consumer preferences and the increasing emphasis on self-care are poised to be key drivers for substantial growth. This trend reflects a shift towards accessible solutions for common health concerns, aligning with consumers' desire for autonomy in healthcare decision-making. The global prevalence of self-medication, especially in demographics like aging populations is expected to be a significant market driver for the Over-the-Counter (OTC) Healthcare Market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Market CAGR for Over-the-Counter (OTC) Healthcare is being driven by the Global trend towards increased consumer empowerment and a growing emphasis on self-care. A prevailing global trend underscores increasing consumer empowerment and a heightened emphasis on self-care. A national survey in the United States revealed that respondents attribute the benefits of self-care to enhanced self-confidence (64%), increased productivity (67%), and heightened happiness (71%). Notably, according to the Global Self-Care Federation, the practice of self-medication gains popularity with age, ranging from 83% in Iran to 35.4% in Saudi Arabia. The prevalence of self-medication is also observed among adolescents in various countries, with notable percentages in Jordan (87%), Palestine (98%), Kuwait (92%), the United Arab Emirates (UAE) (89.2%), and Bahrain (44.8%). Consumers globally are taking a proactive stance in managing their health, seeking accessible solutions for common health issues without the necessity of a prescription. This paradigm shift is fundamentally driven by a desire for convenience and autonomy in healthcare decision-making.
In the Indian market, a significant portion of the population relies on self-medication, and the expanding purchasing power of the middle class further amplifies this trend. The practice of self-medication is anticipated to fuel growth in categories such as cough and cold formulations, gastrointestinal, analgesics, and dermatological drugs. According to a report from MDPI in 2022, the prevalence of self-medication in India stands at approximately 44.9%, with the highest prevalence observed among middle-lower class families at a rate of 26.31%. This widespread inclination toward self-medication signifies a robust demand for Over-the-Counter (OTC) drugs in India, consequently driving growth in the country's market.
As a result, it is anticipated that throughout the projection period, demand for the Over-the-Counter (OTC) Healthcare Market will increase due to the Global trend towards increased consumer empowerment and a growing emphasis on self-care. Thus, driving the Over-the-Counter (OTC) Healthcare Market revenue.
The Over-the-Counter (OTC) Healthcare Market segmentation, based on Category includes Traditional Medicines, Cough, Cold and Allergy Preparations, Analgesics, and Others. The cough, cold, and allergy preparations segment dominated the market, accounting for 58% of market revenue (100.2 Billion). The market benefits from a rising consumer awareness of self-care practices and the accessibility of OTC medications for common ailments. Informed about the symptoms associated with coughs, colds, and allergies, consumers increasingly opt for OTC solutions as a primary means of managing these conditions, indicating a preference for self-directed healthcare over immediate professional medical intervention.
Figure 1: Over-the-Counter (OTC) Healthcare Market, by Category, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The Over-the-Counter (OTC) Healthcare Market segmentation, based on Distribution Channel includes Chemists/Pharmacies, Hypermarkets and supermarkets, E-Retailers, Parapharmacies/Drugstores, and Others. The chemists/pharmacies segment dominated the market, accounting for 58% of market revenue (100.2 Billion). Pharmacies typically stock a diverse range of OTC healthcare products, encompassing cough and cold remedies, pain relievers, allergy medications, vitamins, and various wellness items. This diverse product selection positions pharmacies as all-encompassing destinations that cater to a wide spectrum of consumer needs, solidifying their status as one-stop shops for diverse health and wellness requirements. The current trend of heightened awareness regarding preventive healthcare and self-care practices has prompted consumers to actively seek OTC solutions. Pharmacies, recognized as trusted healthcare providers, actively contribute to and support these trends by offering an array of products designed to promote wellness and address prevalent health concerns. This strategic positioning aligns pharmacies with evolving consumer preferences and positions them as key players in the facilitation of accessible and comprehensive OTC healthcare solutions.
By region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. The anticipated expansion of the Over-the-Counter (OTC) Healthcare market in North America can be attributed to several key factors. The surge in consumer awareness regarding health and wellness, combined with a pronounced emphasis on preventive healthcare, is propelling a heightened demand for Over-the-Counter (OTC) solutions. Currently, approximately 50 percent of U.S. consumers prioritize wellness as a key concern in their daily lives, marking a notable increase from 42 percent in 2020. According to the Global Wellness Institute, North America stands as the foremost regional market for physical activity, accounting for a substantial $361 billion in 2022. OTC products tailored to address wellness, nutritional supplements, and preventive measures are experiencing heightened popularity in response to these overarching health trends, presenting lucrative opportunities for businesses to align their offerings with the evolving preferences of health-conscious consumers.
Further, the major countries studied in the market report are the US, Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: OVER-THE-COUNTER (OTC) HEALTHCARE MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe's Over-the-Counter (OTC) Healthcare Market accounts for the second-largest market share In the European market, akin to several global regions, there is a notable demographic shift characterized by an aging population. As of 2022, over one-fifth (21.1%) of the European Union's (EU) population is aged 65 and above. The median age of the EU's population, recorded at 44.4 years as of January 1, 2022, signifies that half of the population surpasses this age threshold. This demographic trend translates into an increased prevalence of minor health issues among the elderly demographic, presenting a strategic opportunity for Over-the-Counter (OTC) healthcare solutions. The escalating proportion of aged individuals contributes significantly to the sustained demand for OTC products in the European market. Further, the German Over-the-Counter (OTC) Healthcare Market held the largest market share, and the UK Over-the-Counter (OTC) Healthcare Market was the fastest-growing market in the European region
The Asia-Pacific Over-the-Counter (OTC) Healthcare Market is expected to grow at the fastest CAGR from 2023 to 2032. Self-medication refers to the practice of using medications intended for the treatment of common health issues without a prescription from a physician. Recent data from the Journal of Family Medicine and Primary Care (May 2022) reveals that self-medication is widespread in India, with a significant number of individuals resorting to it for ailments like colds, coughs, pain, and fever. According to a survey conducted by the same journal in May 2022, 57.7% of respondents acknowledged practicing self-medication, with 39.8% falling within the age group of 28 to 37 years. Among those opting for self-medication in India, pharmacies emerge as the primary source of information, accounting for 64.3%. Given the substantial percentage of individuals engaging in self-medication in India, the Over-the-Counter (OTC) Healthcare market is poised for rapid growth during the forecast period. Moreover, China’s Over-the-Counter (OTC) Healthcare Market held the largest market share, and the Indian Over-the-Counter (OTC) Healthcare Market was the fastest-growing market in the Asia-Pacific region.
Over-the-Counter (OTC) Healthcare Market Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development to expand their product lines, which will help the Over-the-Counter (OTC) Healthcare market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their global footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, the Over-the-Counter (OTC) Healthcare industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the global Over-the-Counter (OTC) Healthcare industry to benefit clients and increase the market sector. In recent years, the Over-the-Counter (OTC) Healthcare industry has offered some of the most significant advantages to the general public. Major players in the Over-the-Counter (OTC) Healthcare Market, including GSK Plc, Johnson & Johnson Services, Inc., P&G, Bayer AG, Sanofi-Aventis Groupe, Reckitt Benckiser Group plc, Nu Skin Enterprises Inc., Herbalife International Inc., and Abbott Laboratories are attempting to increase market demand by investing in research and development operations.
GSK plc (GSK), a prominent healthcare company, specializes in the development, manufacturing, and commercialization of a diverse portfolio encompassing general medicines, specialty medicines, and vaccines. Its product offerings address a spectrum of diseases, including HIV, respiratory conditions, cancer, immuno-inflammation, anti-viral treatments, central nervous system (CNS) disorders, metabolic disorders, cardiovascular issues, urogenital concerns, anti-bacterial, dermatology, and rare diseases. In addition, GSK provides a range of over-the-counter (OTC) products targeting pain relief, oral health, nutrition, skin health, and gastrointestinal diseases. The company's vaccine portfolio spans various diseases, such as hepatitis, diphtheria, tetanus, whooping cough, rotavirus, HPV infections, measles, bacterial meningitis, and more. GSK distributes its products globally through wholesalers, pharmacies, hospitals, physicians, and various healthcare channels. The corporate headquarters are situated in Brentford, Middlesex, the UK.
Procter & Gamble Co (P&G), a leading manufacturer and marketer of fast-moving consumer goods, boasts a comprehensive product portfolio encompassing items like conditioners, shampoo, razors, toothbrushes, dishwashing liquids, detergents, and various hygiene products. The company markets its products under well-known brand names such as Head & Shoulders, Tide, Ariel, Olay, Pantene, Pampers, Gillette, Braun, and Fusion. P&G strategically distributes its offerings through diverse channels, including grocery stores, online platforms, pharmacies, and department stores, ensuring a global presence across Asia-Pacific, Europe, the Middle East, Africa, and the Americas. The company's headquarters are located in Cincinnati, Ohio, the US.
Key companies in the Over-the-Counter (OTC) Healthcare Market include
Over-the-counter (OTC) Healthcare Industry Developments
October 2022: In October 2022, VirgoCX unveiled the highly anticipated OTC Direct upgrade to its over-the-counter (OTC) trading platform, VirgoCX Wealth, as part of its continuous dedication to delivering optimal tools and user experiences for its clients.
July 2022: In July 2022, AFT Pharmaceuticals and RooLife Group announced the introduction of a selection of AFT's over-the-counter (OTC) pharmaceuticals through their storefront on the China Cross-Border E-Commerce (CBEC) online platform Tmall Global.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 172.8 Billion |
| Market Size 2023 | USD 177.1 Billion |
| Market Size 2032 | USD 215.80 Billion |
| Compound Annual Growth Rate (CAGR) | 2.50% (2023-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2019- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Category, Distribution Channel, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | GSK Plc, Johnson & Johnson Services, Inc., P&G, Bayer AG, Sanofi-Aventis Groupe, Reckitt Benckiser Group plc, Nu Skin Enterprises Inc., Herbalife International Inc., and Abbott Laboratories |
| Key Market Opportunities | Supportive regulatory frameworks and clear guidelines for OTC medications |
| Key Market Dynamics | Aging populations in various regions contribute to the demand for OTC healthcare products |
Frequently Asked Questions (FAQ) :
The Over-the-Counter (OTC) Healthcare Market size was valued at USD 172.8 Billion in 2022.
The Over-the-Counter (OTC) Healthcare Market is projected to grow at a CAGR of 2.50% during the forecast period, 2023-2032.
North America had the largest share of the global market
The key players in the market are GSK Plc, Johnson & Johnson Services, Inc., P&G, Bayer AG, Sanofi-Aventis Groupe, Reckitt Benckiser Group plc, Nu Skin Enterprises Inc., Herbalife International Inc., and Abbott Laboratories.
The Cough, Cold, and Allergy Preparations segment dominated the market in 2022.
The Chemists/Pharmacies segment had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
